Immunohistochemical staining of 34 BLCA samples collected from the local hospital revealed that cases with advanced TNM stages had lower levels of CD96 and OAS1, and higher levels of CSH1 (all P < 0.05, Fig. 4E). Here, CSH1 is linked to bladder transitional cell carcinoma.